Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Oppenheim Website

Joost J. Oppenheim, M.D.

Selected Publications

1)  Yang D, Postnikov YV, Li Y, Tewary P, de la Rosa G, Wei F, Klinman D, Gioannini T, Weiss JP, Furusawa T, Bustin M, Oppenheim JJ.
High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses.
J. Exp. Med. 209: 157-71, 2012.
2)  Yoshimura T, Oppenheim JJ.
Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
Exp. Cell Res. 317: 674-84, 2011.
3)  Chen X, Oppenheim JJ.
Comment on.
J. Immunol. 187: 1527; author reply 1527-8, 2011.
4)  Chen X, Oppenheim JJ.
Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.
FEBS Lett. 3611-8, 2011.
5)  Buzas K, Oppenheim JJ, Zack Howard OM.
Myeloid cells migrate in response to IL-24.
Cytokine. 55: 429-34, 2011.
6)  Chertov O, Zhang N, Chen X, Oppenheim JJ, Lubkowski J, McGrath C, Sowder RC, Crise BJ, Malyguine A, Kutzler MA, Steele AD, Henderson EE, Rogers TJ.
Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture.
PLoS ONE. 6: e14474, 2011.
7)  Qi J, Buzas K, Fan H, Cohen JI, Wang K, Mont E, Klinman D, Oppenheim JJ, Howard OM.
Painful Pathways Induced by TLR Stimulation of Dorsal Root Ganglion Neurons.
J Immunol. 6417-26, 2011.
8)  Song C, Rahim RT, Davey PC, Bednar F, Bardi G, Zhang L, Zhang N, Oppenheim JJ, Rogers TJ.
PKC{zeta} mediates {micro}-opioid receptor-induced cross-desensitization of CCR5.
J Biol Chem. 20354-65, 2011.
9)  Chen X, Oppenheim JJ.
Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.
Int. Immunopharmacol. 11: 1489-96, 2011.
10)  Tarasov SG, Gaponenko V, Howard OM, Chen Y, Oppenheim JJ, Dyba MA, Subramaniam S, Lee Y, Michejda C, Tarasova NI.
Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles.
Proc. Natl. Acad. Sci. U.S.A. 108: 9798-803, 2011.
Click Here to View Expanded Bibliography.

This page was last updated on 5/14/2012.